Control compounds for drug-induced liver injury evaluation: Evidence from Database of Adverse Event Notifications

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-12-04 DOI:10.1016/j.jhep.2024.12.002

Guiying Gao, Guo Yu, Guo-Fu Li

{"title":"Control compounds for drug-induced liver injury evaluation: Evidence from Database of Adverse Event Notifications","authors":"Guiying Gao, Guo Yu, Guo-Fu Li","doi":"10.1016/j.jhep.2024.12.002","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors’ contributions:</h2>Guo-Fu Li concepted and designed the study, analyzed and interpreted the data, and drafted the manuscript; Guiying Gao and Guo Yu contributed to the data collection and analysis; Guo Yu and Guo-Fu Li supervised the study. All authors reviewed and approved the final manuscript.</section></section><section><section><h2>Data availability statement:</h2>The data used in this study can be publicly accessible at <span><span>https://www.tga.gov.au/safety/safety/database-adverse-event-notifications-daen-medicines</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span> in the Database of Adverse Event Notifications.</section></section><section><section><h2>Financial support:</h2>Guo Yu reports receiving grants from Jiangsu Provincial Natural Science Fund for Distinguished Young Scholars (BK20200005).</section></section><section><section><h2>Declaration of Competing Interest:</h2>The authors declare no conflicts of interest that pertain to this work.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"7 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2024.12.002","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Authors’ contributions:

Guo-Fu Li concepted and designed the study, analyzed and interpreted the data, and drafted the manuscript; Guiying Gao and Guo Yu contributed to the data collection and analysis; Guo Yu and Guo-Fu Li supervised the study. All authors reviewed and approved the final manuscript.

Data availability statement:

The data used in this study can be publicly accessible at https://www.tga.gov.au/safety/safety/database-adverse-event-notifications-daen-medicines in the Database of Adverse Event Notifications.

Financial support:

Guo Yu reports receiving grants from Jiangsu Provincial Natural Science Fund for Distinguished Young Scholars (BK20200005).

Declaration of Competing Interest:

The authors declare no conflicts of interest that pertain to this work.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.